Results 81 to 90 of about 422,600 (405)

A new prescription for empirical ethics research in pharmacy: a critical review of the literature [PDF]

open access: yes, 2007
Empirical ethics research is increasingly valued in bioethics and healthcare more generally, but there remain as yet under-researched areas such as pharmacy, despite the increasingly visible attempts by the profession to embrace additional roles beyond ...
Bissell, P., Cooper, R.J., Wingfield, J.
core   +2 more sources

The epithelial barrier theory proposes a comprehensive explanation for the origins of allergic and other chronic noncommunicable diseases

open access: yesFEBS Letters, EarlyView.
Exposure to common noxious agents (1), including allergens, pollutants, and micro‐nanoplastics, can cause epithelial barrier damage (2) in our body's protective linings. This may trigger an immune response to our microbiome (3). The epithelial barrier theory explains how this process can lead to chronic noncommunicable diseases (4) affecting organs ...
Can Zeyneloglu   +17 more
wiley   +1 more source

Advancing the Adoption of Continuing Professional Development (CPD) in the United States

open access: yesPharmacy, 2020
Over the last four decades, the expanded patient care roles of pharmacists in the United States (U.S.) have increased focus on ensuring the implementation of processes to enhance continuing professional development within the profession.
James A. Owen   +2 more
doaj   +1 more source

The pharmacist and the EHR [PDF]

open access: yesJournal of the American Medical Informatics Association, 2016
The adoption of electronic health records (EHRs) across the United States has impacted the methods by which health care professionals care for their patients. It is not always recognized, however, that pharmacists also actively use advanced functionality within the EHR.
Charlene R. Weir   +4 more
openaire   +2 more sources

From omics to AI—mapping the pathogenic pathways in type 2 diabetes

open access: yesFEBS Letters, EarlyView.
Integrating multi‐omics data with AI‐based modelling (unsupervised and supervised machine learning) identify optimal patient clusters, informing AI‐driven accurate risk stratification. Digital twins simulate individual trajectories in real time, guiding precision medicine by matching patients to targeted therapies.
Siobhán O'Sullivan   +2 more
wiley   +1 more source

Insights from Regulatory Data on Development Needs of Community Pharmacy Professionals

open access: yesPharmacy, 2020
The aim of this study was to use data available to a Canadian health professions regulator (Ontario College of Pharmacists) to identify areas of opportunity where practitioners (pharmacists and pharmacy technicians) could benefit from further development,
Katherine Morris, Anita Arzoomanian
doaj   +1 more source

Examining equity in a void of evidence - Pharmacist minor ailments services and the role of systematic reviews

open access: yesExploratory Research in Clinical and Social Pharmacy, 2022
Pharmacist minor ailment services (PMAS) are formalised services which remunerate pharmacists for delivering care and providing medicines used to treat minor ailments such as hayfever, musculoskeletal pain, head lice and constipation.
Joanna Hikaka, Robert Haua
doaj   +1 more source

WHY NOT THE PHARMACISTS? [PDF]

open access: yesJournal of the American Medical Association, 1887
Dear Sir: —The late innovation of having a Section of Dentistry at the Ninth International Medical Congress working so well, and the great excellence of the pharmaceutical display, invite the question, Why not have a Section of Pharmacy in the American Medical Association? It is simply raised for discussion, adding the following memoranda: Pharmacy
openaire   +2 more sources

Effectiveness and cost effectiveness of pharmacist input at the ward level: a systematic review and meta-analysis [PDF]

open access: yes, 2018
Background Pharmacists play important role in ensuring timely care delivery at the ward level. The optimal level of pharmacist input, however, is not clearly defined.
Aag   +57 more
core   +3 more sources

ERBIN limits epithelial cell plasticity via suppression of TGF‐β signaling

open access: yesFEBS Letters, EarlyView.
In breast and lung cancer patients, low ERBIN expression correlates with poor clinical outcomes. Here, we show that ERBIN inhibits TGF‐β‐induced epithelial‐to‐mesenchymal transition in NMuMG breast and A549 lung adenocarcinoma cell lines. ERBIN suppresses TGF‐β/SMAD signaling and reduces TGF‐β‐induced ERK phosphorylation.
Chao Li   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy